User login
Dr. Rowan Chlebowski says his findings suggest an increased risk of non-small cell lung cancer associated with combination hormone therapy in a secondary analysis of data from the Women's Health Initiative study. Damian McNamara of the Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando.
Dr. Rowan Chlebowski says his findings suggest an increased risk of non-small cell lung cancer associated with combination hormone therapy in a secondary analysis of data from the Women's Health Initiative study. Damian McNamara of the Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando.
Dr. Rowan Chlebowski says his findings suggest an increased risk of non-small cell lung cancer associated with combination hormone therapy in a secondary analysis of data from the Women's Health Initiative study. Damian McNamara of the Global Medical News Network (GMNN) reports from the annual meeting of the American Society of Clinical Oncology in Orlando.